BK asthma sufferers face FDA-induced sticker shock

An FDA-madated change has left some Brooklyn asthma sufferers gasping for breath from sticker shock.The FDA has ordered manufacturers to phase out chlorofluorocarbon (CFC) inhalers

FLATBUSH - An FDA-madated change has left some Brooklyn asthma sufferers gasping for breath from sticker shock.

The FDA has ordered manufacturers to phase out chlorofluorocarbon (CFC) inhalers by December 31, 2008. CFC inhalers contain a propellant that allows the medication to quickly reach the lungs, but it also depletes the ozone. Drug companies are switching to environmentally friendly hydrofluoroalkane (HFA) inhalers ahead of time.

Although just as effective, the new inhalers cost more. "The generic albuterol would have cost them $13 to $17 and the new ones ... $30 to $45," says pharmacist Shanel Sattar.

Agnes Greene, who relies on her CFC inhaler daily, was stunned by the change. "I came to get my prescription filled and I found out it's no longer accepted," said Greene.

Health professionals fear patients will try to make their inhalers last to save money instead of using them, putting lives at risk.

Related information:American Lung Association

advertisement | advertise on News 12

Trending Video

Barre originates from ballet, and similarly aims to 1 Ready, Set, Fit: Barre
The MTA announced the 3 station in East 2 MTA: 3 train station to reopen in March
Three people are accused of breaking into the 3 3 accused of breaking into Brooklyn laundromat
Tensions are high for some public school parents 4 Bushwick parents calling out DOE for charter school plans
An 8-year-old who has shown his appreciation for 5 8-year-old spreads police appreciation message

advertisement | advertise on News 12

Features

Sorry to interrupt...

Your first 5 are free

Access to News12 is free for Optimum, Comcast®, Time Warner® and Service Electric℠ video customers.

Please enjoy 5 complimentary views to articles, photos, and videos during the next 30 days.

LOGIN SUBSCRIBE